- Surgical Technology International -

Denton Cooley

Thomas Starzl

Harry J Buncke

Giorgio Brunelli

Serving the Surgical Community for 30 years

Written by Surgeons for Surgeons. SURGICAL TECHNOLOGY INTERNATIONAL features Peer-reviewed articles in key specialty areas. Articles published Online first, providing the most up-to-date information. Accessible via IP access, or via subscription links immediately upon release.

Surgical Technology International is ranked #145 out of the top 841 Peer-reviewed journals in the world on SCOPUS. 82nd percentiles, just 16 percentiles behind the New England Journal of Medicine.

Indexed in Clarivate Analytics services Emerging Sources Citation Index.

120-130 new articles every year. Over 1800 peer-reviewed articles have already been already indexed on PUBMED.

ISSN: 1090-3941 SURGICAL TECHNOLOGY INTERNATIONAL consists of 9 sections – a Surgical Overview section – where readers will find information relating to all surgical specialties, followed by the specialty sections, General Surgery, Cardiovascular Surgery, Advanced Wound Healing, Gynecology, Urology, Bariatric Surgery, Hernia Repair, Orthopaedics, Spine and Neurosurgery.

Articles are sourced from leading Surgeons and Professors from all over the world. Articles also cover aspects of the O.R. from prep, procedure, techniques and tools with a focus on technical innovations.

Latest Issue

Surgical Technology International - Volume 42.

Table of Contents

Edited by:

Zoltán Szabó, PhD, FICS,

Harry Reich, MD, FACOG,

Manabu Yamamoto, MD, PhD,

Harold Brem, MD, FACS,

Michael T. Manley, PhD, FRSA,

Michael A. Mont, MD,

Prof Arnaud Wattiez, MD,

Rifat Latifi, MD, FACS, FICS, FKCS

Previous Issues

Vol. 41

Vol. 40

Vol. 39

Vol. 38

Vol. 37

Vol. 36

Vol. 35

Vol. 34

Vol. 33

Vol. 32

Vol. 31

Vol. 30

Vol. 29

Vol. 28

Vol. 27

Vol. 26

Vol. 25

Vol. 24

Vol. 23

Vol. 22

Vol. 21

Vol. 20

Vol. 19

Vol. 18

Vol. 17

Vol. 16

Vol. 15

Vol. 14

Vol. 13

Vol. 12

Vol. 11

Vol. 10

Vol. 9

Vol. 8

Vol. 7

Vol. 6

Vol. 5

Vol. 4

Vol. 3

Vol. 2

Vol. 1

Surgical Technology International

43nd Edition - New Online Studies

Gaseous Micro-Embolic Activity and Goal-Directed Perfusion Management in a Closed System for Cardiopulmonary Bypass and Minimally Invasive Extracorporeal Circulation during Coronary Artery Bypass Grafting
Ignazio Condello, PhD, Giuseppe Nasso, MD, PhD, Giuseppe Speziale, MD, PhD, Anthea Hospital, Bari, Italy, Kurt Staessens, PhD, UZ Brussels, Jette, Belgium

Clinical Trials

Prospective Randomized Clinical Trial of HEMOPATCH Topical Sealant in Cardiac Surgery

Luca Weltert, MD, Cardiac Surgeon, Heart Surgery Division, Salvatore D’Aleo, MD, Cardiac Surgeon, Heart Surgery Division, Ilaria Chirichilli, MD, Cardiac Surgeon, Heart Surgery Division, Mauro Falco, MD, Anaesthesiologist, Anesthesiology Division, Franco Turani, MD, Anaesthesiologist, Anesthesiology Division, Alessandro Bellisario, MD, Cardiac Surgeon, Heart Surgery Division, Ruggero De Paulis, MD, Cardiac Surgeon, Heart Surgery Division, European Hospital, Rome, Italy

PDF Format - $77.00

This study has been completed.

Sponsor: Cardiochirurgia E.H.

Information provided by (Responsible Party): Luca Weltert, Cardiochirurgia E.H.

ClinicalTrials.gov Identifier:

NCT02133378

First received: May 6, 2014

Last updated: January 26, 2016

Last verified: January 2016

PURPOSE

A new topical hemostatic agent composed of a specifically-formulated porous collagen matrix, coated on one side with a thin protein bonding layer (known as NHS-PEG) has been reported to be extremely effective, in addition to traditional means, in terminating bleeding during cardiac operations with control rates as high as 97,5%. The investigators compared such hemostatic agent (Hemopatch; Baxter Inc, Deerfield, IL) with traditional optimized hemostasis routine. Following sample size calculation, in a prospective randomized study design, 100 patients will be treated with Hemopatch and 100 patients will receive traditional optimized hemostasis routine (comparison group). To make the two cohorts as comparable as possible enrollment will be restricted to moderately bleeding vascular anastomosis of Dacron grafts to ascending aorta or moderately bleeding transversal aortotomy. Study endpoints are the following: rate of successful intraoperative hemostasis (identified by cessation of bleeding in less than 3 minutes from application) and time required for hemostasis; overall postoperative bleeding; rate of transfusion of blood products; rate of surgical revision for bleeding; postoperative morbidity; and intensive care unit stay.

Subscription

Subscribers will receive Online access to our latest editions, (2 volumes per year) as well as a copy of the book. (450 pages per edition) 2 books in total. As a current subscriber you can also purchase articles at a discounted rate from our previous editions, and receive a quarterly content update on upcoming volumes.

Individual

including print and electronic access.

1 year Subscription $399.00

2 year Subscription $679.00

(Save 15%)

Individual copy - Volume 42 - $195.00

Institutional

both electronic and print versions. :

1 year Subscription - $ 1,450.00

2 year Subscription - $2,335.00

(Save 15%)

1 year Subscription - Electronic access - $1,400.00

Single Copy - $375.00

Featured Articles

Meta-Analysis of the Impact of the Learning Curve in Robotic Rectal Cancer Surgery on Histopathologic Outcomes
Mahir Gachabayov, MD, PhD, Research Scholar, Roberto Bergamaschi, MD, PhD, Professor of Surgery and Chief, New York Medical College, Westchester Medical Center, Valhalla, NY, Karen You, BS, Research Assistant, State University of New York, Stony Brook, NY, Seon-Hahn Kim, MD, PhD, Professor of Surgery, Director of Cancer Center, Korea University Anam Hospital, Seoul, Korea, Tomohiro Yamaguchi, MD, PhD, Head, Shizuoka Cancer Center Hospital, Shizuoka, Japan, Rosa Jimenez-Rodriguez, MD, PhD, Associate Head, Hospital Universitario Virgen del Rocio, Sevilla, Spain, Li-Jen Kuo, MD, Head, Division of Colorectal Surgery, Taipei Medical University Hospital, Taipei, Taiwan, Fabio Cianchi, MD, PhD, Professor and Chief, University of Florence, Florence, Italy, Fabio Staderini, MD, Surgery Resident, University of Florence, Florence, Italy

ORDER

Hybrid Repair Techniques for Complex Aneurysms and Dissections Involving the Aortic Arch and Thoracic Aorta 850
Rami Tadros, MD, Associate Professor, Department of Surgery and Radiology, Associate Program Director, Vascular Surgery Residency, Director, Off-site Vascular Lab, Scott R. Safir, MD, Research Fellow, Department of Surgery, Peter L. Faries, MD, Professor, Department of Surgery and Radiology, Program Director, Vascular Surgery Residency, Division of Vascular Surgery, Daniel K. Han, MD, Assistant Professor, Department of Surgery and Radiology, Rajiv K. Chander, MD, Assistant Professor, Department of Surgery, James F. McKinsey, MD, Professor and Vice Chairman, Department of Surgery, Systems Chief of Complex Aortic Intervention for Mount Sinai Health System, Mount Sinai West, Michael L. Marin, MD, Professor and System Chair, Department of Surgery , Division of Vascular Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, Allan S. Stewart, MD, Associate Professor, Department of Cardiovascular Surgery, Icahn School of Medicine at Mount Sinai Hospital, New York, New York, Sharif Ellozy, MD, Associate Professor of Clinical Surgery, Division of Vascular and Endovascular Surgery , Weill Cornell Medical College , New York, New York

ORDER

Value-based Clinical Quality Improvement (CQI) for Patients Undergoing Abdominal Wall Reconstruction (624)
Bradley Stephan, MD, Surgery Resident, PGY3, Halifax Medical Center, Daytona Beach, Florida, Bruce Ramshaw, MD, FACS, Co-Director, Advanced Hernia Solutions, Chairman and Chief Medical Officer, Surgical Momentum, Chairman, General Surgery Residency Program, Halifax Medical Center, Associate Clinical Professor, Florida State University, Daytona Beach, Florida, Brandie Forman, Director, Patient Care Management, Advanced Hernia Solutions, Daytona Beach, Florida ORDER